Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06860516

HLA Demographics Study in Adults With Type 1 Diabetes

A Non-interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
GentiBio, Inc · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes

Detailed description

This is a non-interventional study to evaluate the distribution of human leukocyte antigen (HLA)-DRB1\*04:01 genotype in participants that are recently (within 2 months of the study visit) diagnosed with T1D, with a single blood draw for the analysis of HLA genotype within the study participants. The study duration will be 24 hours and will include a single study visit for the collection of demographic data and a single blood draw, and a follow-up telephone call 24 hours after the study visit.

Conditions

Interventions

TypeNameDescription
OTHERblood drawa blood draw for testing of HLA-DRB1\*04:01

Timeline

Start date
2025-06-06
Primary completion
2026-01-30
Completion
2026-06-01
First posted
2025-03-06
Last updated
2025-09-18

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06860516. Inclusion in this directory is not an endorsement.